Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Curr Osteoporos Rep. 2019 Feb 26;:

Authors: Pignolo RJ, Samsonraj RM, Law SF, Wang H, Chandra A

Abstract
PURPOSE OF REVIEW: We review cell senescence in the context of age-related bone loss by broadly discussing aging mechanisms in bone, currently known inducers and markers of senescence, the senescence-associated secretory phenotype (SASP), and the emerging roles of senescence in bone homeostasis and pathology.
RECENT FINDINGS: Cellular senescence is a state of irreversible cell cycle arrest induced by insults or stressors including telomere attrition, oxidative stress, DNA damage, oncogene activation, and other intrinsic or extrinsic triggers and there is mounting evidence for the role of senescence in aging bone. Cellular aging also instigates a SASP that exerts detrimental paracrine and likely systemic effects. With aging, multiple cell types in the bone microenvironment become senescent, with osteocytes and myeloid cells as primary contributors to the SASP. Targeting undesired senescent cells may be a favorable strategy to promote bone anabolic and anti-resorptive functions in aging bone, with the possibility of improving bone quality and function with normal aging and/or disease.

PMID: 30806947 [PubMed - as supplied by publisher]

from A via a.sfakia on Inoreader https://ift.tt/2XrqddW